Temporal	O
enhancer	O
profiling	O
of	O
parallel	O
lineages	O
identifies	O
AHR	S-GENE
and	O
GLIS1	S-GENE
as	O
regulators	O
of	O
mesenchymal	O
multipotency	O
.	O


Temporal	O
data	O
on	O
gene	O
expression	O
and	O
context	O
-	O
specific	O
open	O
chromatin	O
states	O
can	O
improve	O
identification	O
of	O
key	O
transcription	O
factors	O
(	O
TFs	O
)	O
and	O
the	O
gene	O
regulatory	O
networks	O
(	O
GRNs	O
)	O
controlling	O
cellular	O
differentiation	O
.	O


However	O
,	O
their	O
integration	O
remains	O
challenging	O
.	O


Here	O
,	O
we	O
delineate	O
a	O
general	O
approach	O
for	O
data	O
-	O
driven	O
and	O
unbiased	O
identification	O
of	O
key	O
TFs	O
and	O
dynamic	O
GRNs	O
,	O
called	O
EPIC	O
-	O
DREM	O
.	O


We	O
generated	O
time	O
-	O
series	O
transcriptomic	O
and	O
epigenomic	O
profiles	O
during	O
differentiation	O
of	O
mouse	O
multipotent	O
bone	O
marrow	O
stromal	O
cell	O
line	O
(	O
ST2	O
)	O
toward	O
adipocytes	O
and	O
osteoblasts	O
.	O


Using	O
our	O
novel	O
approach	O
we	O
constructed	O
time	O
-	O
resolved	O
GRNs	O
for	O
both	O
lineages	O
and	O
identifed	O
the	O
shared	O
TFs	O
involved	O
in	O
both	O
differentiation	O
processes	O
.	O


To	O
take	O
an	O
alternative	O
approach	O
to	O
prioritize	O
the	O
identified	O
shared	O
regulators	O
,	O
we	O
mapped	O
dynamic	O
super	O
-	O
enhancers	O
in	O
both	O
lineages	O
and	O
associated	O
them	O
to	O
target	O
genes	O
with	O
correlated	O
expression	O
profiles	O
.	O


The	O
combination	O
of	O
the	O
two	O
approaches	O
identified	O
aryl	B-GENE
hydrocarbon	I-GENE
receptor	E-GENE
(	O
AHR	S-GENE
)	O
and	O
Glis	B-GENE
family	I-GENE
zinc	I-GENE
finger	I-GENE
1	E-GENE
(	O
GLIS1	S-GENE
)	O
as	O
mesenchymal	O
key	O
TFs	O
controlled	O
by	O
dynamic	O
cell	O
type	O
-	O
specific	O
super	O
-	O
enhancers	O
that	O
become	O
repressed	O
in	O
both	O
lineages	O
.	O
AHR	S-GENE
and	O
GLIS1	S-GENE
control	O
differentiation	O
-	O
induced	O
genes	O
and	O
their	O
overexpression	O
can	O
inhibit	O
the	O
lineage	O
commitment	O
of	O
the	O
multipotent	O
bone	O
marrow	O
-	O
derived	O
ST2	O
cells	O
.	O
